|
ZNF30 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.3057000000094E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.793000E-04 |
| Normal-vs-Stage2 |
2.563200E-04 |
| Normal-vs-Stage3 |
8.37870000000018E-05 |
| Normal-vs-Stage4 |
4.41069958334595E-10 |
| Stage1-vs-Stage2 |
6.488000E-02 |
| Stage1-vs-Stage3 |
1.238360E-01 |
| Stage1-vs-Stage4 |
4.06889999999827E-05 |
| Stage2-vs-Stage3 |
5.732600E-01 |
| Stage2-vs-Stage4 |
3.628400E-01 |
| Stage3-vs-Stage4 |
5.336100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.27980000047745E-07 |
| Normal-vs-AfricanAmerican |
5.383600E-02 |
| Normal-vs-Asian |
8.793800E-02 |
| Caucasian-vs-AfricanAmerican |
1.457640E-01 |
| Caucasian-vs-Asian |
2.780600E-03 |
| AfricanAmerican-vs-Asian |
4.192100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.34470000001663E-06 |
| Normal-vs-Female |
8.19450000000277E-05 |
| Male-vs-Female |
5.037800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.472430E-01 |
| Normal-vs-Age(41-60Yrs) |
8.48669999999885E-05 |
| Normal-vs-Age(61-80Yrs) |
1.97640999999305E-05 |
| Normal-vs-Age(81-100Yrs) |
1.5872599999911E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.489400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.867400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.131620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.513800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.877700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.104400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.939800E-01 |
| Normal-vs-Grade 2 |
7.264700E-03 |
| Normal-vs-Grade 3 |
9.54300000133301E-08 |
| Normal-vs-Grade 4 |
8.57220000538561E-08 |
| Grade 1-vs-Grade 2 |
2.790000E-01 |
| Grade 1-vs-Grade 3 |
1.036310E-02 |
| Grade 1-vs-Grade 4 |
4.718100E-03 |
| Grade 2-vs-Grade 3 |
7.557700E-04 |
| Grade 2-vs-Grade 4 |
8.033600E-04 |
| Grade 3-vs-Grade 4 |
2.303600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.096110E-03 |
| Normal-vs-ccB subtype |
1.67648999999104E-05 |
| ccA subtype-vs-ccB subtype |
1.739180E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.57726999999719E-05 |
| Normal-vs-N1 |
5.352900E-04 |
| N0-vs-N1 |
2.872800E-01 |
|
|
